Retatrutide has emerged as a powerful investigational compound in the field of metabolic and adipose tissue research due to its unique activity as a triple-agonist targeting the GLP-1, GIP, and glucagon receptors. This multifaceted mechanism enables researchers to explore complex metabolic pathways involving appetite regulation, energy expenditure, glucose homeostasis, and lipid metabolism with unprecedented precision.